HADHB
protein-codinghydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
Gene summary
This gene encodes the beta subunit of the mitochondrial trifunctional protein, which catalyzes the last three steps of mitochondrial beta-oxidation of long chain fatty acids. The mitochondrial membrane-bound heterocomplex is composed of four alpha and four beta subunits, with the beta subunit catalyzing the 3-ketoacyl-CoA thiolase activity. The encoded protein can also bind RNA and decreases the stability of some mRNAs. The genes of the alpha and beta subunits of the mitochondrial trifunctional protein are located adjacent to each other in the human genome in a head-to-head orientation. Mutations in this gene result in trifunctional protein deficiency. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2013]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~47.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0012172
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0012172
Submitter: ClinGen
Inheritance Pattern: AR
Disease ID:MONDO:0005244
Submitter: LiferaOmics
Genetic evidence – Published: PMID: 24314034 – Reports a patient with early-onset axonal sensorimotor neuropathy due to compound heterozygous HADHB variants (missense and canonical splice; predicted LoF) in trans, with absence of systemic/metabolic features typical of classic mitochondrial trifunctional protein deficiency. Case-level (AR compound heterozygous; evaluate each allele independently: missense = non-LOF, splice = predicted LoF; combined proband score conservatively) = 1.6; segregation = 0; case-control = 0; PMID: 24314034 total = 1.6 PMID: 31130284 – One patient. Case-level (non-LOF missense in AR model; no consanguinity reported) = 0.1; segregation = 0; case-control = 0; PMID: 31130284 total = 0.1 PMID: 30682426 – One Case-level (non-LOF missense in AR model; no consanguinity reported) = 1.0; segregation = 0; case-control = 0; PMID: 30682426 total = 0.1 Published genetic evidence total = 1.8/12 Genetic evidence – Our cases: Family 1 – one proband. Case-level (non-LOF missense in AR model) = 0.1; segregation = 0; case-control = 0; Family 1 total = 0.1 Family 2 – one proband Case-level (non-LOF missense in AR model) = 0.1; segregation = 0; case-control = 0; Family 2 total = 0.1 Our cases total = 1.0/12 Total genetic evidence (published + our cases) 1.8 + 0.2 = 2.0/12 Experimental evidence – Published: None scored for the non-syndromic neuropathy phenotype at this time (no neuropathy-specific functional alteration, model, or rescue evidence meeting ClinGen experimental categories for this phenotype). Experimental evidence total = 0/6 Overall score = 2.0
Inheritance Pattern: AR
Disease ID:MONDO:0958181
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0012172
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: Biochemical
Rationale: Early diagnosis to allow interventions such as avoidance of fasting and urgent metabolic care in the setting of acute metabolic decompensation may reduce morbidity and mortality
Comments: Variants are also related to maternal HELLP syndrome and Acute fatty liver of pregnancy
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to HADHB variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000183.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 136 | 4 | 142 | ||
| missense | 5 | 33 | 146 | 2 | 186 | |
| nonsense | 10 | 6 | 16 | |||
| start loss | 2 | 2 | ||||
| frameshift | 14 | 10 | 1 | 25 | ||
| splice donor/acceptor (+/-2bp) | 4 | 31 | 10 | 45 | ||
| Total | 35 | 80 | 159 | 138 | 4 | 416 |
Highest pathogenic variant AF is 0.00018854727
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000174.1 | 15 | MANE Select | |
| Ensembl | ENSP00000325136.5 | 15 | MANE Select | |
| RefSeq | NP_001268441.1 | 14 | Standard | |
| RefSeq | NP_001268442.1 | 14 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Fatty acid degradation - Homo sapiens (human)
- Fatty acid elongation - Homo sapiens (human)
- Valine, leucine and isoleucine degradation - Homo sapiens (human)
- Long chain acyl-CoA dehydrogenase deficiency (LCAD)
- Trifunctional protein deficiency
Biological Process
- fatty acid beta-oxidation
Molecular Function
- RNA binding
- 3-hydroxyacyl-CoA dehydrogenase activity
- acetyl-CoA C-acyltransferase activity
- enoyl-CoA hydratase activity
- protein binding
Cellular Component
- mitochondrion
- mitochondrial envelope
- mitochondrial outer membrane
- mitochondrial inner membrane
- endoplasmic reticulum
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000317799
- Coding exons
- 15
- Length
- 47299
- Individuals with no LoFs
- 125685
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 63
- Defined
- 125748
- p
- 0.000251
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.649 | 234 | 264 | 0.887 | 0.0000142 | 3071 |
| Missense (PolyPhen) | 91 | 111.7 | 0.8147 | 1336 | ||
| Synonymous | 0.387 | 88 | 92.7 | 0.949 | 0.00000493 | 941 |
| Loss of Function | 1.39 | 21 | 29.1 | 0.722 | 0.00000180 | 322 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00018 | 0.00018 | rare |
| Latino/Admixed American | 0.00038 | 0.00038 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00033 | 0.00033 | rare |
| Finnish | 0.00023 | 0.00023 | rare |
| European (Non-Finnish) | 0.00026 | 0.00025 | rare |
| South Asian | 0.00020 | 0.00020 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Disease
- DISEASE: Mitochondrial trifunctional protein deficiency (MTPD) [MIM:609015]: A disease biochemically characterized by loss of all enzyme activities of the mitochondrial trifunctional protein complex. Variable clinical manifestations include hypoglycemia, cardiomyopathy, delayed psychomotor development, sensorimotor axonopathy, generalized weakness, hepatic dysfunction, respiratory failure. Sudden infant death may occur. Most patients die from heart failure. {ECO:0000269|PubMed:12754706, ECO:0000269|PubMed:8651282, ECO:0000269|PubMed:9259266}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.244
Intolerance Scores
- LoFtool
- 0.320
- RVIS EVS
- -0.54
- RVIS percentile EVS
- 20.54
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.986
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |